Governance structure
The Queensland Immunology Research Centre was established in 2023 by The University of Queensland and QIMR Berghofer Medical Research Institute to promote collaborative research in Immunology and expand its application to improve health outcome for patients with infectious complications, cancer and autoimmune diseases.
The QIRC brings together world-class expertise in Immunology at UQ and QIMR Berghofer to delineate novel insights in immune regulation and use this knowledge to develop breakthrough immune-based therapies and preventive strategies.
In addition, QIRC will also aim to attract talented researchers to The University of Queensland and the QIMR Berghofer Medical Research Institute through collaborative links with national and international academic and industry partners.
Vision
Enhance capabilities in fundamental and translational research in immunology and develop strategies to tackle infectious disease, cancer and autoimmune diseases through immune-based intervention.
MISSION
To be a world leading immunology research centre in health research and training and translating research outcome to novel therapies
To develop collaborative links with international academic and industry organizations to enhance funding opportunities for QIRC researchers
Our Objectives
Collaborate: Further develop links between immunology researchers at UQ and QIMR Berghofer in collaboration with other researchers in Queensland, Australia and globally, to undertake fundamental, translational, and clinical research.
Fund: Attract competitive national and international funding streams and increase alternative funding models (public and private health sectors, industry, philanthropy and corporate partnerships).
Commercialise: Foster and expand existing industry collaborations, attract new industry partners and launch entrepreneurial activities.
Translate: Introduce and develop new preventative strategies, and novel diagnostics, treatments and health delivery models to improve patient outcomes.